Highlights Hikma Pharmaceuticals PLC

Equities

Real-time Estimate Cboe Europe Other stock markets 09:57:14 2024-05-09 EDT			5-day change	1st Jan Change
1,986 ^GBX	+0.66%		+3.06%	+10.90%

05-03	Deutsche Bank Starts Hikma Pharmaceuticals Coverage at Buy	MT
05-03	Jefferies cuts AJ Bell; Deutsche likes ConvaTec	AN

HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets	04-26
Hikma Pharmaceuticals plc Approves Final Dividend, Payable on 3 May 2024	04-25	CI
Hikma Pharmaceuticals backs outlook after making strong start to 2024	04-25	AN
Hikma Pharmaceuticals Affirms FY24 Guidance	04-25	MT
Hikma Pharmaceuticals PLC Proposes Final Dividend for the Full Year 2023	04-25	CI
Hikma Pharmaceuticals plc Reiterates Earnings Guidance for the Year 2024	04-25	CI
Final dividend	03-20	FA
FTSE 100 Closes Up 0.12% Ahead of U.K. Jobs Data	03-11	DJ
AFT Pharmaceuticals to Expand Global Footprint with Signing of Supply, Production Deals	03-03	MT
AFT Pharmaceuticals Limited Extends License for Maxigesic/Combogesic IV with Hikma Pharmaceuticals	03-03	CI
Hyloris Partner Hikma Launches Pain Medication in US, Obtains Approval in Canada	02-28	MT
Merck's Bridion faces generic threat from drugmaker Hikma	02-26	RE
HIKMA PHARMACEUTICALS : Strong Generics-led finish to 2023	02-22
Hikma boosts dividend after year of "significant progress"	02-22	AN
Drugmaker Hikma expects profit to be slightly lower in 2024	02-22	RE
Hikma Pharmaceuticals Reports Improved FY23 Profit, Revenue	02-22	MT
Earnings Flash (HIK.L) HIKMA PHARMACEUTICALS Posts FY23 EPS $0.85	02-22	MT
Hikma Pharmaceuticals PLC Provides Group Earnings Guidance for the Year 2024	02-22	CI
Hikma Pharmaceuticals PLC Reports Earnings Results for the Full Year Ended December 31, 2023	02-22	CI
Stocks to rise as Nvidia drives AI optimism	02-22	AN

No results for this search

HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets

April 26, 2024 at 06:50 am